POS0729 DIFFERENCES BETWEEN GLUCOCORTICOIDS, CONVENTIONAL DMARDS AND TOCILIZUMAB IN ACHIEVING DISEASE REMISSION AND IN PREVENTING THE PROGRESSION OF DAMAGE IN GIANT CELL ARTERITIS PATIENTS